Viewing Study NCT04395859

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-02-11 @ 10:19 AM
Study NCT ID: NCT04395859
Status: COMPLETED
Last Update Posted: 2022-03-03
First Post: 2020-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age Related Macular Degeneration View
None Diabetic Macular Edema View
None Retinal Vein Occlusion View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Intravitreal Injections View
None Anti-angiogenics View
None COVID19 View